Nippon India Pharma Fund - Growth
EquitySector - Healthcare
512.18
4.35(0.86%)
NAV as on 11 Dec, 2025
CAGR
21.41%
- AUM (Crs.)8,458.68
- Expense Ratio1.81 %
- Sharpe Ratio / Category Average0.92 / 0.94
- Standard Deviation / Category Average15.23 / 16.00
- Beta / Category Average0.91 / 0.96
- Portfolio Turnover / Category Average14.27 / 56.14
- Top 5 Stocks Wt.40.26
- Top 10 Stocks Wt.58.53
- Top 3 Sectors Wt.99.66
- Investment StyleLarge Growth
- Morningstar Rating
Portfolio
Asset Allocation
Weightage by Market Cap
Concentration
- No. of Stocks--
- Avg. Market Cap--
- Top 10 Stocks--
- Top 5 Stocks--
- Top 3 Sectors--
View Holdings
Fundamentals
| Measures | Fund | Category Average |
|---|
Risk Metrics
Peers
1Y3Y5Y10Y
| Mutual Fund | AUM (cr.) | 3YReturns |
|---|
Holdings
Stocks
Sector
About
- Fund Manager(s)Check HistorySailesh Raj Bhan, Kinjal Desai, Divya Sharma, Lokesh Maru
- Launch Date05 Jun, 2004
- BenchmarkS&P BSE 500
Objective
The primary investment objective of the scheme is to seek to generate consistent returns by investing in equity and equity related or fixed income securities of Pharma and other associated companies.
Riskometer
More Funds From
| Fund Name | Morningstar Rating | AUM (cr.) | 1Y Returns | 3Y Returns | 5Y Returns |
|---|